Pharmaron Beijing dividend and valuation
Valuation
Pharmaron Beijing paid ¥0.20 per share in dividends over the last 12 months (yield 0.5%). Last ex-dividend date: July 7, 2026. The P/E ratio is 39.3. The average price target of 11 analysts is ¥50.40.
What would Pharmaron Beijing's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 21, 2026
Pharmaron Beijing compared with similar companies
Pharmaron Beijing's P/E (trailing 12 months): 39.3, +7% against the median of a group of 8 similar companies (36.8).
| Metric | Pharmaron Beijing | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 39.3 | 36.8 | 32.6 – 57.4 | Middle |
| Forward P/E | 26.0 | 31.7 | 22.2 – 41.7 | Middle |
| EV/EBITDA | 23.0 | 29.3 | 18.2 – 67.4 | Middle |
| Price/book | 4.16 | 4.16 | 2.56 – 7.85 | Middle |
| Price/sales | 4.42 | 9.88 | 5.78 – 31.6 | Low |
| Gross margin | 33.7% | 74.6% | 56.9% – 79.1% | Low |
| Operating margin | 14.0% | 21.1% | 10.7% – 32.0% | Middle |
| Net margin | 11.1% | 11.1% | 7.2% – 26.8% | Middle |
| ROE | 10.4% | 10.4% | 5.0% – 19.8% | Middle |
| Debt/equity | 0.42 | 0.11 | 0.05 – 0.38 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Pharmaron Beijing: valuation over time
On the latest fiscal year's earnings (2025), Pharmaron Beijing's P/E today is 41.0, below the median of its last 7 fiscal years (58.6; between 25.4 and 81.5 from 2019 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (0.5%) is above the median of the last 7 fiscal years (0.4%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | ¥28.43 | ¥0.94 | 30.3 | ¥0.20 | 0.7% |
| 2024 | ¥25.70 | ¥1.01 | 25.4 | ¥0.20 | 0.8% |
| 2023 | ¥28.98 | ¥0.90 | 32.1 | ¥0.20 | 0.7% |
| 2022 | ¥45.33 | ¥0.77 | 58.6 | ¥0.20 | 0.4% |
| 2021 | ¥62.79 | ¥0.91 | 68.8 | ¥0.20 | 0.3% |
| 2020 | ¥53.51 | ¥0.66 | 81.5 | ¥0.13 | 0.2% |
| 2019 | ¥22.91 | ¥0.37 | 62.2 | ¥0.07 | 0.3% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- ¥70.74B
- Enterprise value
- ¥76.91B
- PEG
- 1.18
- EV/revenue
- 4.80
Profitability and growth
- ROA
- 4.8%
- ROIC
- 8.4%
- Revenue growth (year over year)
- 20.9%
- Earnings growth (year over year)
- 8.9%
Financial health
- Total cash
- ¥4.03B
- Total debt
- ¥7.47B
- Current ratio
- 1.04
- Quick ratio
- 0.69
- Altman Z-Score
- 3.37
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- ¥0.20
- Dividend yield
- 0.5%
- Payout ratio
- 20.4%
- Ex-dividend date
- July 7, 2026
Analysts and estimates
- Average price target
- ¥50.40
- Median price target
- ¥50.60
- High price target
- ¥60.50
- Low price target
- ¥33.80
- Analysts with a price target
- 11
- Consensus
- Buy
- Forward EPS
- ¥1.48
- EPS estimate, current year
- ¥1.18
Shares and trading
- Beta
- 0.69
- Average volume
- 46.27M
- Shares outstanding
- 1.48B
- Float
- 1.26B
- Institutional ownership
- 17.3%
- Insider ownership
- 35.2%
